WINDLAS
Windlas Biotech
Each stock's 10,000-path forecast, rendered as light.
Windlas Biotech (WINDLAS) Stock Analysis & Case Study
Is WINDLAS a good buy? The data-driven verdict.
on the numbers it mixed signals, a Downstox Snapshot Score of 50/100.
On the numbers, Windlas Biotech (WINDLAS) mixed signals, a Downstox Snapshot Score of 50/100, weighing a 46% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
WINDLAS share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of WINDLAS history (7%/yr drift, 45%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| WINDLAS 2027 | ₹443 | ₹782 | ₹1,395 | -4% |
| WINDLAS 2028 | ₹337 | ₹759 | ₹1,722 | -7% |
| WINDLAS 2029 | ₹276 | ₹736 | ₹1,999 | -10% |
| WINDLAS 2030 | ₹225 | ₹710 | ₹2,292 | -13% |
| WINDLAS 2031 | ₹186 | ₹676 | ₹2,505 | -17% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability WINDLAS goes up, or doubles?
The bull case for WINDLAS
- Windlas Biotech is part of the NSE universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,999.
The bear case & risks
- No model or past record guarantees future returns, treat this as one input, not a decision.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹276.
WINDLAS volatility & expected range, how bumpy is the ride?
Over the last 2.0 years WINDLAS compounded at 7%/year with annualized volatility of 45%. That volatility implies a 1-year 80% range of ₹443–₹1,395, the honest backbone behind any single price target.
WINDLAS price forecast, the full 60-month probability fan
WINDLAS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds WINDLAS hits common targets within the simulated horizon?
Full multi-horizon detail on the WINDLAS price target & forecast page.
WINDLAS MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy WINDLAS with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 33.4% | 3.0× |
| Dhan | 40.0% | 2.5× |
Compare every broker on the WINDLAS MTF page.
WINDLAS vs peers,sector comparison
About Windlas Biotech: sector, index & market-cap context
Windlas Biotech (WINDLAS) is an NSE-listed company.
How the WINDLAS Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Windlas Biotech's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
WINDLAS analysis, FAQs
Is Windlas Biotech (WINDLAS) a good buy?
On the numbers, Windlas Biotech (WINDLAS) mixed signals, a Downstox Snapshot Score of 50/100, weighing a 46% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is WINDLAS overvalued or undervalued?
Valuation ratios for WINDLAS are tracked live on Downstox.
What is the WINDLAS share price target for 2031?
WINDLAS's probability-weighted 2031 median target is ₹676, with an 80% range of ₹186–₹2,505 (10,000-path Monte-Carlo).
What is the probability WINDLAS doubles in 5 years?
The modelled probability of WINDLAS reaching ₹1,632 (2×) within 5 years is 20%.
What is the bull case for WINDLAS?
Windlas Biotech is part of the NSE universe with live, tracked fundamentals on Downstox.
What are the risks in WINDLAS?
No model or past record guarantees future returns, treat this as one input, not a decision.